WallStreetZenWallStreetZen

NASDAQ: QLGN
Qualigen Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Qualigen Therapeutics earnings were -$7.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest QLGN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$1.7M, down 36.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QLGN reported annual earnings of -$6.3M, with -52.7% growth.

QLGN earnings history

Current Revenue
$0.0
Current Earnings
-$7.0M
Current Profit Margin
0%

QLGN Return on Equity

Current Company
N/A
Current Industry
-10%
Current Market
30.7%

QLGN undefined

Current Company
-203.1%
Current Industry
-0.2%
QLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when QLGN announces earnings.

QLGN undefined

Current Company
380.76%
Current Industry
6.4%
QLGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

QLGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
QLGN-$6.29M-$7.01MN/A-$0.14
XRTX-$1.30M-$1.37MN/A-$0.35
DRMA-$10.33M-$10.33MN/A-$4.66
GLTO-$16.57M-$16.59MN/A-$13.14
ENVB-$9.65M-$9.94MN/A-$10.58
View Top Biotech Stocks

Qualigen Therapeutics Earnings Reports & History FAQ

What were Qualigen Therapeutics's earnings last quarter?

Qualigen Therapeutics (NASDAQ: QLGN) reported Q2 2025 earnings per share (EPS) of -$1.00, up 90.36% year over year. Total QLGN earnings for the quarter were -$1.69 million. In the same quarter last year, Qualigen Therapeutics's earnings per share (EPS) was -$10.37.

If you're new to stock investing, here's how to buy Qualigen Therapeutics stock.

Is Qualigen Therapeutics profitable or losing money?

As of the last Qualigen Therapeutics earnings report, Qualigen Therapeutics is currently losing money. Qualigen Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$6.98 million, a 28.57% decrease year over year.

What was QLGN's earnings growth in the past year?

As of Qualigen Therapeutics's earnings date in Q3 2025, Qualigen Therapeutics's earnings has grown year over year. QLGN earnings in the past year totalled -$7.01 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.